Dio Tree
PrivateLast Round
Seed
Dec 1, 2022
Total Funding Raised
$400,000
Company Overview
Dio Tree is a biotechnology company that develops a novel, first-in-class, small molecule for the treatment of ovarian cancer by inhibiting the DIO3 enzyme.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dio Tree Comparables
Compare Dio Tree with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Algok Bio, Inc. | 75% | |
| OnCusp | 71% | |
| Zentalis | 65% | |
Dio Tree Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 1, 2022 |
Dio Tree Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Seed |
| NGT HealthCare II | Seed |
| Arieli Group | Seed |
| Hadasit - Hadassah Medical Center's Technology Transfer Company | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2022
$400K raised from Arieli Group, NGT HealthCare II, and others.
Dio Tree Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Dio Tree's valuation, stock price, and market status.